As more patients turn to GLP-1 medications for weight management and diabetes care, navigating insurance coverage and out-of-pocket costs has become increasingly challenging. To help simplify the process, Hartig Drug has introduced a more defined GLP-1 Coordination and Education Program, where pharmacists have resources to help to connect patients with programs that may significantly reduce the cost of their medication.
The program serves as a one-stop resource for patients prescribed GLP-1 medications such as Wegovy®, Zepbound®, Ozempic®, Foundayo®, and Mounjaro®. Under the...





